Thirteen patients with dementia of Alzheimer type and nine age-matched control subjects were examined by a battery of neuropsychological tests and by positron emission tomography (PET) with "C-deoxyglucose as a tracer for regional glucose metabolism in the brain. Concentrations of the monoamine metabolites HVA, MHPG and 5-HIAA were determined in the CSF from patients and controls. In the patients there was a diminished glucose metabolism in posterior parietal and superior temporal cortex areas to 60% of control levels. Other cortical areas showed similar changes, whereas the pre-and postcentral area, the cerebellum, the hippocampus and the basal ganglia showed less or no change. The decline in cortical metabolism in the patients was symmetrical but the variation in the left/right ratio was greater than in the controls. The Using cerebral blood flow measurements, evidence of decreased metabolic activity in posterior parietal and temporal cortex areas of demented patients has been found.'0 A similar pattern of focal cortical changes has been described by positron emission tomography (PET) using "0 for measurement of oxygen utilisation" or '8F-deoxyglucose for measurement of regional glucose metabolism. 12-5 The results of these investigations are in good agreement with histopathological studies where the posterior parietal and temporal cortex areas have been reported to have the highest density of neuritic plaques. '6 To further investigate the relationship between brain pathophysiology and cognitive defects in Alzheimer's disease we conducted a study using PET with "C-deoxyglucose as tracer. Patients with a clinical diagnosis of Alzheimer's disease and healthy volunteers were subjected to a thorough medical and psychological examination including an analysis of monoamine metabolites in the CSF. Correlations between regional glucose metabolism, neuropsychological test performance and CSF metabolites were calculated. A question particularly addressed was whether specific neuropsychological defects are related to the glucose metabolism of specific brain regions. 
temporal cortex areas to 60% of control levels. Other cortical areas showed similar changes, whereas the pre-and postcentral area, the cerebellum, the hippocampus and the basal ganglia showed less or no change. The decline in cortical metabolism in the patients was symmetrical but the variation in the left/right ratio was greater than in the controls. The CSF levels of monoamine metabolites did not differ between patients and controls. High levels of the metabolites were associated with low rates of glucose metabolism, possibly due to inhibitory influences of monoaminergic pathways upon cortical and subcortical neurons. The rate of glucose metabolism correlated positively with the neuropsychological test performance in both patients and controls. Verbal and memory performances were associated with greater left hemisphere metabolism in the patients, but not in the controls, whereas non-verbal abilities tended to be associated with right hemisphere metabolic dominance.
Senile dementia of Alzheimer type has been associated with deficits in various monoaminergic neurotransmitter systems in the brain. The memory dysfunction and the intellectual decline have been shown to correlate with reduced levels of choline acetyltransferase in cortical brain biopsies and in postmortem brain material.'" Also levels of noradrenaline, dopamine and serotonin and their metabolites are reduced in the brains of patients dying with dementia.45 Studies of brain transmitter systems in living patients have to be performed with indirect methods. Measurements of levels of monoamine metabolites in the CSF have given controversial results with some authors reporting decreased levels in demented patients67 and others reporting normal levels compared with control subjects.89
Using cerebral blood flow measurements, evidence of decreased metabolic activity in posterior parietal and temporal cortex areas of demented patients has been found.'0 A similar pattern of focal cortical changes has been described by positron emission tomography (PET) using "0 for measurement of oxygen utilisation" or '8F-deoxyglucose for measurement of regional glucose metabolism. The results of these investigations are in good agreement with histopathological studies where the posterior parietal and temporal cortex areas have been reported to have the highest density of neuritic plaques. '6 To further investigate the relationship between brain pathophysiology and cognitive defects in Alzheimer's disease we conducted a study using PET with "C-deoxyglucose as tracer. Patients with a clinical diagnosis of Alzheimer's disease and healthy volunteers were subjected to a thorough medical and psychological examination including an analysis of monoamine metabolites in the CSF. Correlations between regional glucose metabolism, neuropsychological test performance and CSF metabolites were calculated. A question particularly addressed was whether specific neuropsychological defects are related to the glucose metabolism of specific brain regions. collected in ice-cooled centrifuge tubes with the subject in a sitting position. Nine healthy volunteers, four men and five women with a mean age of 66 years (range 61-73) served as a control group. They were recruited through a questionnaire sent to a random sample of individuals aged between 60 and 80 years in the catchment area of the hospital. The volunteers were subjected to the same medical examination, laboratory tests, CT scan, psychiatric interview and psychological tests for the exclusion of diseases that could interfere with brain function. They spent the night before the spinal tap at the research ward to make the conditions for the CSF sampling identical between patients and controls.
"C-2-Deoxyglucose was synthesised as described by Stone-Elander et al.23 A bolus containing 100-300 MBq (2-7-8 1 mCi) of the tracer dissolved in 5-10 ml of sterile saline was injected iv with the subject in a sitting position, eyes open and ears plugged. The lights were dimmed and the ambient noise was limited as much as possible. Serial, arterial blood samples were taken from the contralateral arm for determination of radioactivity and glucose concentrations. After 26 minutes an individually fitted head fixation device24 was put onto the subject who was laid down and fixed into the positron camera. The brain activity was collected during two consecutive scans of 10 minutes each. The head fixation technique allowed us to receive slices from the same planes as in the CT scanner. The positron camera (PC-384, Scanditronix AB) has four rings, each with 96 detectors that accept coincidences in both direct and oblique planes, thus producing seven simultaneous parallel images from the base of the skull to the vertex (10 cm).25 The spatial resolution ofthe reconstructed images is 7-6 mm full width at half maximum (FWHM). The left/right quotients were close the control subjects but slightly be] indicating a relative left-sided metabolism, in the patients (fig 4) . The Hippo in the left/right ratio was significantly greater in 0 the demented patients indicating a greater asymmetry of brain activity than in the healthy controls.
Rates of "C-deoxyglucose accumulation caudate As some ofthe tests used are claimed to reflect tatistical activity of the left or the right hemisphere fferences specifically left/right ratios were correlated to hough in verbal, non-verbal and memory abilities. We eemed to found, in the patients but not in the controls, that verbal and memory performances were to one in associated with relative left hemisphere hyperlow one, metabolism ( fig 6) whereas non-verbal abilities hypo-were more associated with a relative right variance hemisphere hypermetabolism. Table 2 Correlations between rates ofglucose metabolism in basal ganglia and cortical areas in healthy controls (n = 9) and patients with Alzheimer's dementia (n = 13). Table 3 Correlations between regional glucose metabolism and CSF monoamine metabolites in healthy controls (n = 9) and patients with Alzheimer's dementia (n = 13). However, as the CT images of the patients showed only minor morphological changes we interpret the decline in glucose utilisation as evidence for inactive or malfunctioning neurons. Almost all brain regions displayed a significant decline in glucose utilisation which is in line with the global decrease in mental performance during the progress of the disease. With a relative sparing of the occipital and the preand postcentral cortex it can be imagined that the patients have their primary visual and sensory-motor ability preserved while they lack tween metabolite levels and glucose utilisation ( Nybadck, Nyman, Blomqvist, Sjogren, Stone-Elander brain regions involved the coefficients were with few exceptions positive, some of them reaching significant levels.
The association of results from tests claimed to be sensitive to left hemisphere function with glucose utilisation in regions of the same hemisphere ( fig 6) constitutes a corroboration of current theories about lateralisation of verbal and non-verbal abilities.
Despite the significant correlations between regional glucose utilisation and neuropsychological test results (table 4, figs 5 and 6) our findings do not indicate a simple relationship between local brain activity and specific cognitive abilities. The results rather support the view that verbal, non-verbal and memory functions involve a cooperation between various neuronal systems with different cerebral extensions.
An alternative conclusion could of course be that the PET technique with "C-deoxyglucose is still a crude instrument for describing brain work in relation to mental capacities. The evolution of new PET instruments with higher resolution and studies of brain activity during the performance of cognitive tasks may in the future provide us with further knowledge ofthe relation between regional brain activity and neuropsychological functions. 
